ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Osteoarthritis"

  • Abstract Number: 161 • 2013 ACR/ARHP Annual Meeting

    H3K9 Demethylation By LSD1 Contributes To IL-1-Induced mPGES-1 Expression In OA Chondrocytes

    Fatima Ezzahra El Mansouri1 and Hassan Fahmi2, 1Pharmacology, Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame Hospital, Montreal, QC, Canada, 2Pharmacology, Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada

    Background/Purpose: Microsomal prostaglandin E synthase-1 catalyzes the terminal step in the biosynthesis of PGE2, which plays a critical role in the pathophysiology of osteoarthritis. To…
  • Abstract Number: 2121 • 2013 ACR/ARHP Annual Meeting

    Total Hip Arthroplasty Outcomes In Patients With Psoriatic Arthritis, Osteoarthritis With Cutaneous Psoriasis, and Osteoarthritis

    Lisa A. Mandl1, Rebecca Zhu2, Wei-Ti Huang3, Michael Alexiades4, Mark P. Figgie5 and Susan M. Goodman1, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Clinical Research, Hospital for Special Surgery, New York, NY, 3Biostatistics, Hospital for Special Surgery, New York, NY, 4Orthopaedics, Hospital for Special Surgery, New York, NY, 5Orthopedics, Hospital for Special Surgery, New York, NY

    Background/Purpose: Outcomes of total hip replacements (THR) in psoriatic arthritis (PsA) are poorly studied.  Previous studies are conflicting, often not separating inflammatory PsA from osteoarthritis…
  • Abstract Number: 261 • 2013 ACR/ARHP Annual Meeting

    Concordance Of Hip Pain With Radiographic Hip Osteoarthritis In An Urban US Community: The Framingham Osteoarthritis Study

    Kyu Chan Kim1, David T. Felson2, Katherine D. Linsenmeyer3, Ali Guermazi4, Steven C. Vlad5, Mary M. Clancy6 and Jingbo Niu7, 1Internal Medicine and Rheumatology, Boston Medical Center, Boston, MA, 2Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 3Internal Medicine, Boston Medical Center, Boston, MA, 4Boston University, Boston, MA, 5Clinical Epidemiology, Boston University, Boston, MA, 6School of Medicine, Boston University, Boston, MA, 7Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA

    Background/Purpose: While it is well known that knee pain and radiographic knee osteoarthritis (OA) are often discordant, little is known of the concordance of hip…
  • Abstract Number: 150 • 2013 ACR/ARHP Annual Meeting

    A Subset Of Osteoarthritis Individuals Has Elevated IL-6 Pathway Activation Associated With Worse Symptoms

    Michael Kuziora1, Zheng Liu2, Brandon W. Higgs2, Philip Brohawn2, Kim Lehmann2, Fernanda Pilataxi2, Katie Streicher2, Lydia Greenlees1, Meina Liang3, Rozanne Lee4, Amy Schneider4, Raffaella Faggioni4, Yihong Yao2 and Koustubh Ranade2, 1Translational Science, MedImmune, LLC, Gaithersburg, MD, 2Translational Sciences, MedImmune, LLC, Gaithersburg, MD, 3Dmpk, MedImmune, LLC, Hayward, CA, 4DMPK, MedImmune, LLC, Hayward, CA

    Background/Purpose:  Elevated levels of the pro-inflammatory cytokine IL-6 have been found in the affected joint of patients with osteoarthritis (OA), although the prevalence of OA…
  • Abstract Number: 2103 • 2013 ACR/ARHP Annual Meeting

    Relationships Between Self-Efficacy, Outcome Expectancy, and Outcomes In Older Adults With Osteoarthritis Of The Knee and Hypertension: Baseline Results

    Elizabeth A. Schlenk1, Deborah Crowley-Lisowski1, Sarah Twerski1, Alice Fallon1, Alyssa Sartore1, Susan Sereika1, Joan Rogers2, G. Kelley Fitzgerald3 and C. Kent Kwoh4, 1School of Nursing, University of Pittsburgh, Pittsburgh, PA, 2School of Health and Rehabilitation Sciences, Occupational Therapy, University of Pittsburgh, Pittsburgh, PA, 3School of Health and Rehabilitation Sciences, Physical Therapy, University of Pittsburgh, Pittsburgh, PA, 4School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Staying Active with Arthritis (STAR), an intervention guided by Bandura’s Self-Efficacy Theory, is being investigated in an ongoing clinical trial of an individually delivered,…
  • Abstract Number: 263 • 2013 ACR/ARHP Annual Meeting

    “Generalized Osteoarthritis”: A Systematic Review

    Amanda E. Nelson1, Michael W. Smith2 and Yvonne M. Golightly3, 1University of North Carolina Thurston Arthritis Research Center, Chapel Hill, NC, 2Rheumatology, Saint Luke's Hospitals, Kansas City, MO, 3Gillings School of Global Public Health, Dept of Epidemiology, Thurston Arthritis Research Center, Injury Prevention Research Center, University of North Carolina Dept of Epidemiology, Chapel Hill, NC

    Background/Purpose: To perform a systematic review of definitions, risk factors, and outcomes in "generalized osteoarthritis" (GOA). Methods: We performed a systematic review of Medline literature…
  • Abstract Number: 2108 • 2013 ACR/ARHP Annual Meeting

    Pre- and Postoperative Physical Therapy In Total Hip and Knee Replacement Surgery:  A Multi Center Study

    Wilfred FH Peter1,2, Claire Tilbury3, Rutger Tordoir4, Suzan Verdegaal5, Ron Onstenk6, Menno Benard7, Stephan Vehmeijer8, Enrike van der Linden-van der Zwaag1, Eric Vermeulen1, Rob Nelissen1 and Thea VlietVlieland9, 1Department of Orthopaedics, Leiden University Medical Center, Leiden, Netherlands, 2Reade, center for rehabilitation and rheumatology, Amsterdam, Nicaragua, 3Departement of Orthopedics, Leiden University Medical Center, Leiden, Netherlands, 4Departement of orthopedics, Rijnland Hospital, Leiderdorp, Netherlands, 5Departement of Orthopedics, Rijnland Hospital, Leiderdorp, Netherlands, 6Department of Orthopedics, Het Groene Hart Hospital, Gouda, Netherlands, 7Departement of Orthopedics, Reinier de Graaf Hospital, Delft, Netherlands, 8Department of Orthopedics, Reinier de Graaf Hospital, Delft, Netherlands, 9Department of Orthopaedics, Leids University Medical Center, Leiden, Netherlands

    Background/Purpose: Physical therapy  shown to be effective after Total Hip and Knee Arthroplasty.  Less evidence is available for preoperative physical therapy  in Total Hip and…
  • Abstract Number: 264 • 2013 ACR/ARHP Annual Meeting

    The Proportion Of Knee Osteoarthritis Patients In Southern Sweden That Seek Medical Car

    Aleksandra Turkiewicz1, Maria Gerhardsson de Verdier2, Gunnar Engström3, Stefan Lohmander1 and Martin Englund1, 1Department of Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden, 2Astra Zeneca R&D Molndal, Molndal, Sweden, Molndal, Sweden, 3Dept of Cardiovascular epidemiology, Clinical Sciences, Lund University, Lund, Sweden

    Background/Purpose: To provide estimates of the proportion of subjects with knee osteoarthritis (OA) that seek healthcare for knee OA or joint pain within an 8-year…
  • Abstract Number: 2913 • 2013 ACR/ARHP Annual Meeting

    The Validity Of Patient-Reported Short-Term Complications Following Total Hip and Knee Arthroplast

    Leslie R. Harrold1, David Ayers2, Regis O'Keefe3, Courtland Lewis4, Vincent Pellegrini5 and Patricia D. Franklin2, 1University of Massachusetts Medical School, Worcester, MA, 2Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, 3University of Rochester Medical Center, Rochester, NY, 4Hartford Hospital, Hartford, CT, 5Medical University of South Carolina, Charleston, SC

    Background/Purpose: Given the absence of national longitudinal data on patients who undergo total joint arthroplasty (TJA) and the limitations of hospital databases to capture information…
  • Abstract Number: 1887 • 2013 ACR/ARHP Annual Meeting

    Interleukin-1 Receptor Antagonist (IL-1Ra) Plasma Levels Predict Radiographic Progression Of Symptomatic Knee Osteoarthritis Over 24 Months

    Mukundan Attur1, Alexander Statnikov2,3, Jonathan Samuels4, Svetlana Krasnokutsky1, Jeffrey D. Greenberg1, Zhiguo Li2, Leon Rybak5, Constantin F. Aliferis2,6 and Steven B. Abramson7, 1Division of Rheumatology, Department of Medicine, NYU Hospital for Joint Diseases, New York, NY, 2Center for Health Informatics and Bioinformatics, NYU Langone Medical Center, New York, NY, 3Division of Translational Medicine, NYU Langone Medical Center, New York, NY, 4Division of Rheumatology, Department of Medicine, NYU Langone Medical Center, New York, NY, 5Department of Radiology, NYU Langone Medical Center, New York, NY, 6Department of Pathology, NYU Langone Medical Center, New York, NY, 7Dept of Rheumatology/Medicine, NYU Langone Medical Center, New York, NY

    Background/Purpose: Osteoarthritis is multi-factorial complex degenerative joint disease that leads to permanent joint damage. We and others have shown elevated levels of inflammatory and anti-inflammatory…
  • Abstract Number: 253 • 2013 ACR/ARHP Annual Meeting

    Higher Leg Extensor Muscle Power Output Is Associated With Reduced Pain and Better Quality Of Life In Patients With Symptomatic Knee Osteoarthritis

    Kieran F. Reid1, Lori Lyn Price2, William F. Harvey3, Jeffrey B. Driban3, Roger A. Fielding1 and Chenchen Wang3, 1Nutrition, Exercise Physiology and Sarcopenia Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, 2Biostatistics Research Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 3Rheumatology, Tufts Medical Center, Boston, MA

    Background/Purpose: Muscle strength, the maximal force generating capacity of skeletal muscle, has been widely characterized in patients with knee osteoarthritis. However, skeletal muscle power, defined…
  • Abstract Number: 2720 • 2013 ACR/ARHP Annual Meeting

    Providing Comprehensive, Comparative Post-TJR Outcome Feedback To Surgeons For Quality Monitoring and Value Decisions

    Patricia D. Franklin1, Bruce Barton2, Leslie R. Harrold3, Wenjun Li1, Regis O'Keefe4, Jeroan Allison2 and David Ayers1, 1Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, 2Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, 3University of Massachusetts Medical School, Worcester, MA, 4University of Rochester Medical Center, Rochester, NY

    Background/Purpose: With the CMS decision to publicly report hospital-specific post-operative total joint replacement (TJR) events and readmissions, surgeons and hospitals need comprehensive post-hospital data by…
  • Abstract Number: 1817 • 2013 ACR/ARHP Annual Meeting

    The Clinical Burden Of Generalized Osteoarthritis Represented By Activity Limitations and Health Related Quality Of Life: A Cross-Sectional Study

    Nienke Cuperus1, Thea Vliet Vlieland2, Elien Mahler1, Clarinda Kersten1, Thomas Hoogeboom3 and Els van den Ende1, 1Department of Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, 2Department of Orthopaedics, University Medical Center Leiden, Leiden, Netherlands, 3Department of Epidemiology, CAPHRI school for public health and primary care, CCTR centre for Care Technology Research, Maastricht University, Maastricht, Netherlands

    Background/Purpose: A growing body of evidence shows that generalized osteoarthritis (GOA) is fairly common, however research and clinical practice recommendations are mainly focused on a…
  • Abstract Number: 101 • 2013 ACR/ARHP Annual Meeting

    Trends In Prescription Of Opioids From 2003-2009 In Persons With Knee Osteoarthritis

    Elizabeth Wright1, Jeffrey N. Katz2, Stanley Abrams3, Daniel H. Solomon4 and Elena Losina5, 1Orthopedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 2Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA, 3Orthopedics and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 4Division of Pharmacoepidemiology, Harvard Medical School, Brigham and Women's Hospital, Division of Rheumatology, Division of Pharmacoepidemiology, Boston, MA, 5Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Osteoarthritis (OA) of the knee is a painful condition affecting ~13% of persons >65 years of age. OA is often accompanied by comorbidities. Effective…
  • Abstract Number: 2668 • 2013 ACR/ARHP Annual Meeting

    A Randomized, Double-Blind, Dose Ranging Study Comparing FX006, An Intra-Articular (IA) Sustained-Release Formulation Of Triamcinolone Acetonide (TCA), To An Approved Injectable Suspension Of TCA In Patients With Osteoarthritis (OA) Of The Knee

    Neil Bodick1, Joelle Lufkin1, Christina Willwerth1, Pierre Lachance2, Gregory Jasey3, Anil Gupta4, Anthony Chris5, Marc Russo6, Michael O'Mahony7, Sam Henein8, Louise Murdoch9, Ferdinandus de Looze10, David Hunter11 and Michael Clayman1, 1Flexion Therapeutics, Burlington, MA, 2Clinique St-Louis (Recherche) Inc, Quebec, QC, Canada, 3North Walkerville Orthopaedic Associates, Windsor, ON, Canada, 4Anil K. Gupta Medicine Professional Corporation, Toronto, ON, Canada, 5Aim Health Group, Waterloo, ON, Canada, 6Hunter Clinical Research, Broadmeadow, Australia, 7London Road Diagnostic Clinic and Medical Centre, Sarnia, ON, Canada, 8SKDS Research Inc., Newmarket, ON, Canada, 9Emeritus Research, Malvern East, Australia, 10AusTrials Pty Limited, Sherwood, Australia, 11Royal North Shore Hospital, St. Leonards, Australia

    Background/Purpose: FX006 is a novel sustained-release formulation of TCA in poly(lactic-co-glycolic) acid microspheres intended to maintain therapeutic concentrations in the joint  up to 3 months…
  • « Previous Page
  • 1
  • …
  • 64
  • 65
  • 66
  • 67
  • 68
  • …
  • 71
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology